Ratiopharm plots 600 layoffs

Ratiopharm plans to cut 600 jobs over the next 18 months, as it seeks to reduce its annual operating costs by approximately €100 million. The move will affect one in nine of the company's global workforce of 5,400 staff. Report

Suggested Articles

Teva is reportedly going for a moonshot with a $15 billion drug offer to settle its opioid cases. It's a plan that might just work, one analyst said.

CSL has sued a former exec who its says stole thousands of key documents as he left for competitor Pharming.

Influential U.S. cost watchdog ICER gave its blessing to Johnson & Johnson and Amarin's CV drugs. But there's a big catch for both meds.